Definition
A tandem mass tag (TMT) is an isobaric chemical labeling reagent used in quantitative proteomics to enable simultaneous identification and relative quantification of peptides from multiple biological samples in a single liquid chromatography–tandem mass spectrometry (LC‑MS/MS) experiment. The tag consists of a mass‑balanced reporter group, a balance (or “mass normalizer”) group, and an amine‑reactive functional group that covalently attaches to the N‑terminus and lysine side chains of peptides.
Principle of operation
- Labeling – Peptide samples are individually reacted with distinct TMT reagents, each containing a reporter ion of a unique nominal mass (e.g., 126–131 Da in the original 6‑plex set).
- Mixing – After labeling, the samples are combined into a single mixture, preserving the relative abundance of each peptide species.
- Fragmentation – During MS/MS (collision‑induced dissociation, higher‑energy collisional dissociation, or similar), the isobaric tags fragment to release the reporter ions. Because the tags are isobaric, the precursor ions from all samples appear as a single peak in the MS¹ spectrum.
- Quantification – The intensities of the reporter ions detected in the low‑mass region of the MS² spectrum reflect the relative abundance of the corresponding peptide across the multiplexed samples.
Historical development
The concept of isobaric tagging for multiplexed quantification was introduced in the early 2000s. Tandem mass tags were first described in peer‑reviewed literature in the mid‑2000s and subsequently commercialized by Thermo Fisher Scientific (originally by a company later acquired by Thermo). Initial commercial kits supported 2‑plex and 6‑plex multiplexing; later versions expanded the multiplexing capacity to 10‑plex, 11‑plex, 16‑plex, and the most recent 18‑plex and 24‑plex formats.
Applications
- Differential proteomics: Comparative analysis of protein expression across disease states, treatment conditions, or developmental stages.
- Post‑translational modification (PTM) mapping: Quantitative profiling of phosphorylation, acetylation, ubiquitination, and other PTMs when combined with enrichment strategies.
- Biomarker discovery: High‑throughput screening of clinical specimens to identify candidate diagnostic or therapeutic targets.
- Systems biology: Integrated multi‑omics workflows where proteomic data are combined with transcriptomic or metabolomic datasets.
Advantages
- Multiplexed analysis reduces instrument time and variability compared with separate LC‑MS runs.
- Isobaric nature preserves chromatographic and ionization properties across labeled samples, minimizing bias.
- High sensitivity: Reporter ions are detected at low m/z, allowing accurate quantification even for low‑abundance peptides.
Limitations
- Ratio compression: Co‑isolation of co‑eluting peptides can lead to underestimation of true fold changes, a phenomenon mitigated by synchronous precursor selection (SPS) MS³ acquisition or real‑time searching.
- Cost: Commercial TMT reagents are relatively expensive, which may limit large‑scale studies.
- Instrument requirements: Reliable reporter ion quantification benefits from high‑resolution, accurate‑mass spectrometers capable of rapid MS³ or MSⁿ workflows.
Commercial availability
Thermo Fisher Scientific provides a suite of TMT reagents under the brand name “Tandem Mass Tag.” Kits are supplied as lyophilized reagents for 2‑plex, 6‑plex, 10‑plex, 11‑plex, 16‑plex, 18‑plex, and 24‑plex multiplexing, together with recommended protocols, quality‑control standards, and software tools for data analysis (e.g., Proteome Discoverer, Skyline).
See also
- Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)
- Stable isotope labeling by amino acids in cell culture (SILAC)
- Label‑free quantification
- Mass spectrometry–based proteomics
References
(Encyclopedic entry compiled from peer‑reviewed literature on quantitative proteomics and product information from major reagent suppliers; specific citation details omitted to avoid fabrication.)